Abstract
After introducing chirality with the winding columns of baroque altars and snail shells, the enantioselective hydrogenation of dehydroamino acids is described. Then, the enantioselective homo Diels-Alder reaction of norbornadiene with phenylacetylene is presented, which leads to 8-phenyldeltacyclene in almost enantiomerically pure form. Its reaction with 1,2-bisphosphanylbenzene affords P,P,P-tris(9-phenyldeltacyclan-8-yl)-1,2-bisphosphanylbenzene, a chelate ligand with 3 chiral deltacyclanyl substituents and a PH bond, comprising 24 asymmetric carbon atoms of a given configuration and a stereogenic secondary phosphorus atom. This chelate ligand forms mononuclear, phosphido-bridged dinuclear and - most unusual - trinuclear Ni, Pd and Pt complexes. The trinuclear complexes consisting of three joint square planar units are unique in Ni, Pd and Pt chemistry.
Keywords: pt phosphane complexes, chiral 9-phenyldeltacyclanyl substituent
Current Organic Chemistry
Title: Right or Left - Enantioselective Catalysis. New Ni, Pd and Pt Phosphane Complexes with the Chiral 9-Phenyldeltacyclanyl Substituent
Volume: 6 Issue: 5
Author(s): Henri Brunner
Affiliation:
Keywords: pt phosphane complexes, chiral 9-phenyldeltacyclanyl substituent
Abstract: After introducing chirality with the winding columns of baroque altars and snail shells, the enantioselective hydrogenation of dehydroamino acids is described. Then, the enantioselective homo Diels-Alder reaction of norbornadiene with phenylacetylene is presented, which leads to 8-phenyldeltacyclene in almost enantiomerically pure form. Its reaction with 1,2-bisphosphanylbenzene affords P,P,P-tris(9-phenyldeltacyclan-8-yl)-1,2-bisphosphanylbenzene, a chelate ligand with 3 chiral deltacyclanyl substituents and a PH bond, comprising 24 asymmetric carbon atoms of a given configuration and a stereogenic secondary phosphorus atom. This chelate ligand forms mononuclear, phosphido-bridged dinuclear and - most unusual - trinuclear Ni, Pd and Pt complexes. The trinuclear complexes consisting of three joint square planar units are unique in Ni, Pd and Pt chemistry.
Export Options
About this article
Cite this article as:
Brunner Henri, Right or Left - Enantioselective Catalysis. New Ni, Pd and Pt Phosphane Complexes with the Chiral 9-Phenyldeltacyclanyl Substituent, Current Organic Chemistry 2002; 6 (5) . https://dx.doi.org/10.2174/1385272024604943
DOI https://dx.doi.org/10.2174/1385272024604943 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design Potential Therapeutic Targets in Cirrhotic Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study
Current HIV Research Genetic Lipodystrophies: Models for Insulin Resistance
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents A Review on Analytical Methods of Irbesartan and its Combinations in Pharmaceutical Dosage Forms
Current Pharmaceutical Analysis How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
Current Pharmaceutical Design Bioactive Peptides - Are There More Antihypertensive Mechanisms Beyond ACE Inhibition?
Current Pharmaceutical Design Manipulation of Microglial Activation as a Therapeutic Strategy in Alzheimers Disease
Current Medicinal Chemistry Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide
Current Medicinal Chemistry Isosteviol Protects H9c2 Cells Against Hypoxia-reoxygenation by Activating ERK1/2
Cardiovascular & Hematological Disorders-Drug Targets The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy
Current Clinical Pharmacology Adipokines and Adipocyte Targets in the Future Management of Obesity and the Metabolic Syndrome
Mini-Reviews in Medicinal Chemistry Natural Anticoagulant Proteins in the Regulation of Autoimmunity: Potential Role of Protein S
Current Pharmaceutical Design Liposomes: Targeted and Controlled Delivery System
Drug Delivery Letters Editorial (Thematic Issue: Targeting Phosphodiesterases (PDEs) for Treatment of CNS Diseases)
Current Pharmaceutical Design Pulmonary Hypertension secondary to Left Heart Disease
Current Vascular Pharmacology Oxidative Stress and NAD+ in Ischemic Brain Injury: Current Advances and Future Perspectives
Current Medicinal Chemistry Modulation of Sirtuins: New Targets for Antiageing
Recent Patents on CNS Drug Discovery (Discontinued) ACKNOWLEDGEMENTS TO REVIEWERS
Current Hypertension Reviews Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design